+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 18Years
All Genders
ID04425421

Treatment Recommendations for Children Up to 18 Years Old With Burkitts Lymphoma Including Early Diagnosis and Use of Rituximab

Led by French Africa Pediatric Oncology Group · Updated on 2026-03-02

1000

Participants Needed

7

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to improve treatment for children with Burkitts Lymphoma across at least 14 Sub Saharan countries, some new to this type of study. It focuses on earlier evaluation of children with stage I and II disease and earlier assessment of treatment response to decide if changes are needed. It also intends to intensify treatment for children with stage IV disease. Starting in 2026, the study will assess adding rituximab to current treatments and compare results with earlier implementations in two specific centers. The study involves observing the ability of treatment centers to follow the established GFA LMB2019 protocol for Burkitts Lymphoma. In two units, an amendment adds four rituximab injections during induction treatment, given on day 1 and day 6 of each induction cycle, depending on the risk group and treatment regimen. Other centers will continue using the original GFA LMB2019 treatment protocol without rituximab. Participants will be monitored over five years to evaluate the number of cases diagnosed with local disease and by stage, the treatments given, follow-up after treatment, and relapse rates. The study will also assess how well therapeutic recommendations are applied. This long-term observation helps understand treatment outcomes and the impact of adding rituximab in selected centers.

CONDITIONS

Brief Title

Recommendations for the Treatment of Children With Burkitt's Lymphoma

Research Team

C

Chantal Ms BOUDA, Dr.

B

BRENDA MALLON, MSc PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here